Recent consolidations in the life sciences industry are sending waves, not ripples, throughout the industry. In 2015, mergers and acquisitions – such as the record $160 billion Pfizer/Allergan deal - reached an all-time high, with 362 deals totaling $397.5 billion.1 But every M&A comes with a unique set of workforce challenges that, if not managed correctly, can have drastic bottom line consequences. Check out four strategies that will help ensure workforce continuity and productivity during periods of organizational change:Recent consolidations in the life sciences industry are sending waves, not ripples, throughout the industry. In 2015, mergers and acquisitions – such as the record $160 billion Pfizer/Allergan deal - reached an all-time high, with 362 deals totaling $397.5 billion.1 But every M&A comes with a unique set of workforce challenges that, if not managed correctly, can have drastic bottom line consequences. Check out four strategies that will help ensure workforce continuity and productivity during periods of organizational change: